Astrana Health Business Model Canvas

Partnerships with hospitals and health systems secure admissions management, preferred referral pathways, and coordinated discharge planning to improve throughput and capture referral revenue. Co-developed protocols target a reduction in 30-day readmissions versus the US Medicare baseline of about 15%, with transitional-care programs showing up to ~25% readmission reductions in meta-analyses. Timely data-sharing accelerates transitions of care and strategic affiliations expand service coverage and specialty depth.

Astrana's payer, provider, post-acute, and tech partners secure capitated revenue, coordinated care pathways, and analytics-driven population health, targeting 2–4% TCOC reductions and fewer 30-day readmissions. Medicare Advantage (≈32M enrollees in 2024) and Medicaid MCO coverage (~69% of beneficiaries in 2024) underpin scale and PMPM predictability. Integrated EHR/HIE and analytics (health analytics market ≈$38B in 2024) enable real-time risk stratification.

Pre-auth, concurrent review and post-acute placement reduce unnecessary spend by steering care to guideline-based options; appropriate use criteria have cut low-value imaging by about 20% in real-world programs. Evidence-based guidelines drive consistent approvals and authorization accuracy. Peer-to-peer review improves provider alignment and acceptance. Denial-management data—initial claim denial rates averaging 5–10% in 2024—feeds continuous improvement.

Multidisciplinary teams coordinate care, cutting 30-day readmissions up to 20% and targeting top 5% who drive ~50% of costs. Medication reconciliation finds discrepancies in >50% of encounters; social needs screening connects to community resources. Value management (pre-auth, concurrent review) reduced low-value imaging ~20%; denial rates 5–10% in 2024. Provider network supports MA access amid >30M MA enrollees in 2024.

Capitation agreements and shared-savings frameworks are core assets, mirroring industry models where CMS ACOs produced shared savings in roughly 40% of cases in recent years (2022–2024). Adequate IBNR and risk pools, typically maintained at about 2–4% of earned premium per NAIC practice, ensure solvency against claim volatility. Stop-loss and reinsurance, with common attachment points near $250k per member and aggregate coverage at 125–140% of expected claims, protect downside. Contract terms encode quality incentives via pay-for-performance metrics and risk-adjusted benchmarks tied to utilization and outcomes.

Clinical workforce (PCPs, specialists, care managers), local clinics and clinical leadership enable longitudinal, specialty and high-acuity care, addressing ~90% of US spend drivers.

Interoperable data (claims, certified EHRs 96% 2023), SDOH inputs (~80% outcome influence) and real‑time analytics drive risk stratification and gaps closure.

Payment risk pools (IBNR 2–4% premium), capitation/shared‑savings (CMS ACOs saved ~40% cases 2022–24), stop‑loss ~$250k attachment protect solvency.

Capitated models deliver budget certainty and measurable quality by aligning payment to outcomes rather than fee-for-service, reducing financial volatility for payers. Robust reporting supports CMS Star Ratings (5 domains in 2024) and HEDIS (more than 90 measures as of 2024), enabling performance tracking. Strong utilization controls mitigate trend through care-management and prior-authorization workflows. Strategic partnership creates clear market differentiation for payers and providers.

Coordinated, evidence-based care cuts avoidable utilization (~15–20% fewer readmissions/ER visits) and ~10–15% lower total cost for high‑risk cohorts. Centralized navigation and digital outreach improve adherence (~20%) and reduce no‑shows, lowering post‑discharge returns. Capitated/value contracts and MSO support drive revenue uplift (12%/physician) and shared‑savings (~$150k/group, 2024).

Physician partnership model emphasizes high-touch provider relations teams that deliver dedicated onboarding and ongoing support to a network of clinicians; as of 2024 there are roughly 1.06 million active US physicians (AMA), underscoring scale. Incentives and real-time dashboards align financial and clinical goals and drive measurable engagement. Structured training and office support reduce friction during adoption. Advisory councils formalize clinician feedback into product and ops roadmaps.

Outbound campaigns, care managers, and education use Medicare RPM/CPT codes 99453–99458 to sustain adherence; provider relations support 1.06M US physicians and MA partnerships (30M+ enrollees) for scale. Omnichannel support (portal 78% of non-urgent contacts, telehealth +30% in 2024) with 24/7 nurse line, 12 languages, 99.9% uptime and secure messaging (-35% resolution).

Patients access records, appointments, and secure messaging via digital portals and mobile apps, with 2024 adoption estimates showing roughly 70% of active patients using portals monthly for at least one task.

Providers use real-time dashboards to monitor clinical performance and care gaps, reducing missed follow-ups and readmissions by up to 15% in pilot programs.

Self-service booking and triage cut administrative friction and phone volume by ~40%, while integrated analytics track engagement, retention, and conversion metrics for continuous optimization.

Channels mix in-person clinics, telehealth (~12% of visits in 2024), payer-led attribution (Medicare Advantage ~50%, top‑5 payers ~60% coverage) and digital portals (≈70% monthly users) to drive access and retention; multichannel outreach (phone/SMS/email) lifts adherence +15–20% and cuts admin volume ~40%, while discharge coordination targets 30‑day readmissions (~13% CMS 2024) and ~60% post‑acute capture.

Commercial members (~150 million covered) and ~15 million ACA enrollees in 2024 prioritize convenient, cost-effective care; telehealth and digital triage (≈10% of primary care visits in 2024) plus after-hours access drive satisfaction. Network breadth and high quality scores (HEDIS/NCQA ratings) strongly influence plan choice, and employer condition-management programs report 15–25% reductions in absenteeism.

Managed care (MA >30M, ~52% Medicare 2024), Medicaid MCOs (71% of Medicaid in MCOs), commercial/employer (~155M covered) and ~15M ACA members prioritize cost, access and quality. Seniors/Medicaid (≈65.3M Medicare; 82–88M Medicaid) need chronic care coordination. Physicians (MSO gains 15–25%) and 6,000+ hospitals join for risk programs and referral lift.

Licenses, cloud, interoperability and cybersecurity represent steady operational outlays for Astrana, with healthcare breach costs averaging about 10.93 million USD per incident (IBM, 2023) highlighting security stakes. Analytics and automation need upfront investment for models and ETL pipelines. Device procurement and telehealth platforms add per-patient platform and maintenance expenses. Active vendor management and consolidation materially optimize total tech spend.

Capitated risk makes inpatient, pharmacy and behavioral utilization the primary cost drivers (U.S. hospital spend ~31% of NHE, pharmacy ~11%, behavioral ~7–8%). Clinical staffing typically consumes ~55–65% of operating costs; productivity tech reduced clinician hours per panel ~20–30% in 2024. Security, licensing and stop-loss reinsurance add fixed and tail-risk spend; payer sales cycles run 9–12 months.

Fee-for-service billing complements Astrana Health’s value-based contracts by capturing episodic revenue from professional services and ancillary procedures; in 2024 the Medicare Physician Fee Schedule conversion factor was $33.8872, anchoring FFS pricing. Rigorous coding integrity and documentation drive capture and reduce denials, boosting realized yield. Payer mix—commercial, Medicare Advantage, traditional Medicare—materially influences per-visit margins.

Capitated PMPM is Astrana’s predictable core revenue, risk-adjusted (HCC) and scaled by panel size; Medicare Advantage enrollment ~52% in 2024 expands capitation opportunity. Shared-savings/quality bonuses typically add 5–15% of revenue; MA quality bonuses up to ~5% in 2024. FFS supplements revenue (2024 conversion factor $33.8872). MSO fees and downstream distributions (median shared-savings ~3.8% in 2024) diversify cash flow.